Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Apr 11, 2019 Trogarzo® Receives Positive Recommendation from Scientific Advisory Group of CHMP in Europe Apr 04, 2019 Theratechnologies Announces Financial Results for the First Quarter of 2019 Apr 01, 2019 Study Confirms Tesamorelin Significantly Reduces Liver Fat in HIV Patients With NAFLD Mar 29, 2019 Theratechnologies Appoints New Board Member Mar 28, 2019 Theratechnologies to Announce Financial Results for First Quarter 2019 Mar 20, 2019 European Medicines Agengy Issues Certificates for Trogarzo® Manufacturing Sites Mar 08, 2019 New Trogarzo® Data Presented at Conference on Retroviruses and Opportunistic Infections Demonstrates Sustained Viral Suppression at Week 96 Mar 05, 2019 Trogarzo® to be Reviewed by Scientific Advisory Group of CHMP in Europe Mar 04, 2019 FDA Authorizes Study Protocol for New Mode of Administration for Trogarzo® Feb 25, 2019 Theratechnologies Acquires Targeted Oncology Company Katana Biopharma Inc. First page « Previous page ‹ … Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Page 26 Page 27 … Next page › Last page » Displaying 221 - 230 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Apr 11, 2019 Trogarzo® Receives Positive Recommendation from Scientific Advisory Group of CHMP in Europe
Mar 08, 2019 New Trogarzo® Data Presented at Conference on Retroviruses and Opportunistic Infections Demonstrates Sustained Viral Suppression at Week 96
